Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer
Science Advances · 16.06.2023 · 9 (24)
DOI: 10.1126/sciadv.adf5464 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 16.06.2023. Verfasst von Fei Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guan…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Colonic Neoplasms. Die Arbeit wurde bisher 248-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In this study, we comprehensively charted the cellular landscape of colorectal cancer (CRC) and well-matched liver metastatic CRC using single-cell and spatial transcriptome RNA sequencing. We generated 41,892 CD45 − nonimmune cells and 196,473 CD45 + immune cells from 27 samples of six CRC patients, and found that CD8_CXCL13 and CD4_CXCL13 subsets increased significantly in liver metastatic samples that exhibited high proliferation ability and tumor-activating characterization, contributing to better prognosis of patients. Distinct fibroblast profiles were observed in primary and liver metastatic tumors. F3 + fibroblasts enriched in primary tumors contributed to worse overall survival by expressing protumor factors. However, MCAM + fibroblasts enriched in liver metastatic tumors might promote generation of CD8_CXCL13 cells through Notch signaling. In summary, we extensively analyzed the transcriptional differences of cell atlas between primary and liver metastatic tumors of CRC by single-cell and spatial transcriptome RNA sequencing, providing different dimensions of the development of liver metastasis in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
- Department of General Surgery, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong 510080, China.
- School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China.
- Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
- Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong 510080, China.
ORCID-Profile: Fei Wang, Jie Long, Liang Li, Hai-Qing Ma, Zhe-Xiong Lian, Zhi-Bin Zhao, Jie Cao
Zitieren
APA
Wang, F., Long, J., Li, L., Wu, Z. X., Da, T. T., Wang, X. Q., Huang, C., Jiang, Y. H., Yao, X. Q., Ma, H. Q., Lian, Z. X., Zhao, Z. B., & Cao, J. (2023). Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer. Science Advances, 9(24). https://doi.org/10.1126/sciadv.adf5464
Vancouver
Wang F, Long J, Li L, Wu ZX, Da TT, Wang XQ, et al. Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer. Science Advances. 2023;9(24). doi:10.1126/sciadv.adf5464
BibTeX
@article{Wang2023,
author = {Wang, Fei and Long, Jie and Li, Liang and Wu, Zi-Xin and Da, Tian-Tian and Wang, Xiao-Qing and Huang, Chuan and Jiang, Yi-Hua and Yao, Xue-Qing and Ma, Hai-Qing and Lian, Zhe-Xiong and Zhao, Zhi-Bin and Cao, Jie},
title = {Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {24},
doi = {10.1126/sciadv.adf5464}
}
EUVIMED